Follow

'Prosecutors described Balwani as an “equal participant” in helping Theranos defraud investors of more than $900mn in funding — which gave the company a valuation of $9bn — on the promise its technology could carry out a range of tests on a single drop of blood.

Instead, the machines failed to perform as promised, as later revealed by whistleblowers, and the company entered a death spiral that has become symbolic of Silicon Valley’s risk-taking culture.'

ft.com/content/c456dfb5-34d2-4

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.